输液治疗市场规模、份额和成长分析（按产品、适应症、治疗方法、应用、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，全球输液治疗市场规模将达到 474.3 亿美元，到 2025 年将达到 506.1 亿美元，到 2033 年将达到 850.2 亿美元，预测期（2026-2033 年）的复合年增长率为 6.7%。

由于人口老化、慢性病盛行率上升以及输液技术的进步，全球输液治疗市场正经历显着成长。该市场能够将药物直接有效地输送到血液中，确保精准给药并最大限度地减少副作用，从而有助于改善治疗效果。输液治疗用途广泛，涵盖多种应用，包括药物和必需营养素的输注。它通常在门诊进行，从而降低住院成本。然而，潜在的併发症，例如感染风险和对专业操作人员的需求，也可能带来挑战。随着对有效医疗解决方案的需求不断增长，尤其是在居家医疗领域，输液治疗市场预计将持续成长，因为它对患者照护的创新和效率做出了重大贡献。

全球输液治疗市场驱动因素

慢性疾病（包括癌症、糖尿病和心血管疾病）发生率的不断上升，显着增加了对输液治疗产品和服务的需求。随着越来越多的人面临这些长期健康挑战，医疗服务提供者越来越依赖先进的输液解决方案来有效输送必需的药物和营养素。这种对输液治疗日益增长的依赖反映了整个医疗保健领域的更广泛趋势，即个人化和高效的治疗方案对于管理复杂疾病至关重要。因此，在输液治疗在改善患者预后和提高医疗品质方面发挥的关键作用的推动下，该市场正经历强劲成长。

全球输液治疗市场面临的限制因素

全球输液治疗市场面临的一大挑战是输液治疗产品和服务的高成本。这个问题在开发中国家医疗资源匮乏，阻碍了这些必要疗法的普及。由于医疗体系面临财务压力，输液治疗的高昂成本可能会使病患和医疗服务提供者都不愿使用这些关键服务。因此，在资源匮乏地区，输液治疗的成本效益仍是改善病患就医途径和确保有效治疗的关键因素。解决此限制因素对于市场成长和改善医疗效果至关重要。

全球输液治疗市场趋势

全球输液治疗市场正经历着向居家医疗解决方案的显着转变，这主要得益于患者对居家输液治疗日益增长的偏好。这一趋势凸显了患者对便利性、舒适性和成本效益的需求，促使他们更倾向于在熟悉且充满支持的环境中接受医疗程序。随着医疗保健系统日益重视以患者为中心的模式，输液治疗领域也不断调整以满足对便利居家照护服务的需求，从而推动了创新技术和携带式设备的发展。这种转变不仅改善了患者的治疗效果，也促使医疗服务提供者拓展服务范围，从而改变了传统的静脉输液治疗模式。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球输液治疗市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 点滴帮浦
  • 携带式输液泵
  • 固定式输液泵
  • 注射输液帮浦
  • 一次性泵浦
  • 大容量泵
  • 弹性体泵
• 点滴器
• 配件

全球输液治疗市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 癌症
• 消化系统疾病与紊乱
• 郁血性心臟衰竭
• 类风湿性关节炎
• 血友病
• 免疫力缺乏
• 其他的

全球输液治疗市场规模（依治疗方法类型划分）及复合年增长率（2026-2033 年）

• 抗生素/抗病毒药物
• 抗凝血治疗
• 止吐药
• 血液成分刺激因子
• 化疗
• 营养
• 水合作用
• 疼痛管理

全球输液治疗市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 化疗
• 糖尿病
• 消化系统疾病
• 疼痛管理
• 其他的

全球输液治疗市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 诊所
• 居家医疗环境

全球输液治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • Option Care Health Inc.（美国）
  • 百特国际有限公司（美国）
  • ICU Medical, Inc.（美国）
  • B.Braun Melsungen AG（德国）
  • 泰尔茂株式会社（日本）
  • 穆格公司（美国）
  • 费森尤斯股份公司（德国）
  • 史密斯医疗（英国）
  • JMS株式会社（日本）
  • 凯撒利亚医疗电子（以色列）
  • CareFusion公司（美国）
  • Poly Medicure Limited（印度）
  • 日本尼普洛株式会社
  • 美敦力公司（爱尔兰）
  • 贝克顿·迪金森公司（BD）（美国）
  • 3M公司（美国）
  • 泰利福公司（美国）
  • 爱德华生命科学公司（美国）
  • 科乐普公司（丹麦）
  • 康维泰克集团有限公司（英国）

结论与建议

Global Infusion Therapy Market size was valued at USD 47.43 Billion in 2024 and is poised to grow from USD 50.61 Billion in 2025 to USD 85.02 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global infusion therapy market is experiencing significant growth, propelled by an aging population, the rising incidence of chronic diseases, and advancements in infusion technology. This market segment allows for efficient administration of medications directly into the bloodstream, facilitating precise dosing while minimizing side effects and enhancing treatment outcomes. Infusion therapy is versatile, encompassing various applications, including the delivery of medications and essential nutrients, and often occurs in outpatient settings, which can lower hospitalization costs. However, potential complications such as infection risks and the need for skilled administration can pose challenges. As the demand for effective healthcare solutions rises, especially within home healthcare contexts, the infusion therapy market is anticipated to thrive, contributing greatly to patient care innovations and efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segments Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The rising incidence of chronic illnesses, including cancer, diabetes, and cardiovascular conditions, has significantly heightened the need for infusion therapy products and services. As more individuals face these long-term health challenges, healthcare providers are increasingly turning to advanced infusion solutions to deliver essential medications and nutrients effectively. This growing reliance on infusion therapy reflects a broader trend in healthcare, where tailored and efficient treatment options are becoming crucial for managing complex conditions. Consequently, the infusion therapy market is experiencing robust growth driven by the essential role these therapies play in improving patient outcomes and enhancing the quality of care.

Restraints in the Global Infusion Therapy Market

A significant challenge facing the Global Infusion Therapy market is the elevated costs linked to infusion therapy products and services. This issue is particularly pronounced in developing nations, where limited healthcare access can hinder the adoption of these essential treatments. As financial constraints impact healthcare systems, the high expenses associated with infusion therapy may deter both patients and healthcare providers from utilizing these vital services. Consequently, the affordability of infusion therapy remains a crucial factor for improving patient access and ensuring effective treatment in regions where resources are scarce. Addressing this restraint is essential for market growth and improved healthcare outcomes.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is witnessing a notable shift towards home-based healthcare solutions, driven by rising patient preference for home infusion therapy. This trend emphasizes the desire for convenience, comfort, and cost-effectiveness, leading to a greater inclination for receiving medical treatment in familiar and supportive environments. As healthcare systems increasingly prioritize patient-centered approaches, the infusion therapy segment is adapting to meet demands for accessible home care services, bolstering growth in innovative technologies and portable devices. This transition not only enhances patient outcomes but also prompts healthcare providers to expand their services, thereby transforming the traditional landscape of intravenous therapy delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2026-2033)

• Market Overview
• Infusion Pumps
  • Ambulatory Infusion Pumps
  • Stationary Infusion Pumps
  • Syringe Infusion Pumps
  • Disposable Pumps
  • Large Volume Pumps
  • Elastomeric pumps
• Infusion Set
• Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Cancer
• Gastrointestinal Diseases/Disorders
• Congestive Heart Failure
• Rheumatoid Arthritis
• Hemophilia
• Immune Deficiencies
• Others

Global Infusion Therapy Market Size by Therapy & CAGR (2026-2033)

• Market Overview
• Antibiotic/Antiviral
• Anti-coagulation
• Anti-emetics
• Blood Component Stimulating Factor
• Chemotherapy
• Nutrition
• Hydration
• Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chemotherapy
• Diabetes
• Gastrointestinal Diseases
• Pain management
• Others

Global Infusion Therapy Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

Global Infusion Therapy Market Size & CAGR (2026-2033)

• North America (Product, Indication, Therapy, Application, End-user)
  • US
  • Canada
• Europe (Product, Indication, Therapy, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, Therapy, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, Therapy, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, Therapy, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Option Care Health Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caesarea Medical Electronics (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations